Title:
中枢神経系の癌の治療のための操作されたＴ細胞の投与
Document Type and Number:
Japanese Patent JP7189019
Kind Code:
B2
Abstract:
An improved method of treating cancers with engineered T cells is described.
More Like This:
Inventors:
Buddy, Benham
Brown, Christine E.
Forman, Stephen Jay.
Priceman, Sole Jay.
Brown, Christine E.
Forman, Stephen Jay.
Priceman, Sole Jay.
Application Number:
JP2018540862A
Publication Date:
December 13, 2022
Filing Date:
February 06, 2017
Export Citation:
Assignee:
City of Hope
International Classes:
A61K35/17; A61P25/00; A61P35/00; A61P35/04
Other References:
Brown, C.E. et al.,Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma,Clinical Cancer Research,2015年,Vol.21, No.18,p.4062-4072,doi:10.1158/1078-0432.CCR-15-0428
Glantz, M. et al.,Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay,Seminars in Oncology,2009年,Vol.36, No.4, Suppl.2,p.S17-S24,doi:10.1053/j.seminoncol.2009.05.003
Sun, M. et al.,Construction and evaluation of a novel humanized HER2-specific chimeric receptor,Breast Cancer Research,2014年,Vol.16, No.3,R61,doi:10.1186/bcr3674
大野 忠夫,細胞医薬 生きている細胞を用いるがんの免疫療法,ファルマシア,2000年,第36巻,第8号,p.683-687
Glantz, M. et al.,Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay,Seminars in Oncology,2009年,Vol.36, No.4, Suppl.2,p.S17-S24,doi:10.1053/j.seminoncol.2009.05.003
Sun, M. et al.,Construction and evaluation of a novel humanized HER2-specific chimeric receptor,Breast Cancer Research,2014年,Vol.16, No.3,R61,doi:10.1186/bcr3674
大野 忠夫,細胞医薬 生きている細胞を用いるがんの免疫療法,ファルマシア,2000年,第36巻,第8号,p.683-687
Attorney, Agent or Firm:
Tadashige Ito
Tadahiko Ito
Shinsuke Onuki
Tadahiko Ito
Shinsuke Onuki
Previous Patent: Vibration reduction system and method for power tools
Next Patent: PRODUCTION OF VISCOSE RAYON FILAMENT
Next Patent: PRODUCTION OF VISCOSE RAYON FILAMENT